Loading...
•
Jun 30, 2023
NRC Q2 2023 Earnings Report
NRC Health's financial performance for Q2 2023 decreased compared to the same period last year, but new sales increased.
Key Takeaways
NRC Health announced its Q2 2023 results, which included a 53% increase in new sales compared to Q2 2022 and adoption of the Human Understanding Program by 39 healthcare organizations. The company's diluted earnings per share decreased to $0.29, and the company funded innovation and growth, dividend payments, and share repurchases.
New sales increased by 53% compared to the second quarter of 2022.
Adoption of the Human Understanding Program reached 39 healthcare organizations.
Operating margins improved in the second quarter compared to the first quarter.
Diluted earnings per share decreased to $0.29 for the quarter ended June 30, 2023, from diluted earnings per share of $0.33 for the quarter ended June 30, 2022.
Forward Guidance
The Company’s Board of Directors maintained its capital allocation priorities of funding innovation and growth investments, including merger and acquisition activity, as well as internal projects, shareholder dividends and share repurchases during 2023.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...